Vol. XVIII · Free shipping $75+ · Read the collection
Login Register
Feature · Product Review
c ebpβ-lip drug

c ebpβ-lip drug C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

CCAAT Enhancer Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding Research Purified anti C EBP beta 2 isoforms C EBP beta, LAP Antibody anti C EBP beta A16 C EBP regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages Science Immunology Purified anti C EBP beta 3 isoforms C EBP beta, LAP, LIP Antibody anti C EBP beta 1H7 A) Domain organization of C EBP family members. Each C EBP protein Download Scientific Diagram

SKU: 46611781141 · From crisbcreativa.com

4.8
USD24.22 USD53.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 6 - Oct 11

Description

Food and Drug Administration doesnt monitor the manufacture or sale of supplements or herbs

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

Stress can also lead to procrastination, avoidance behaviors, and burnout, making it difficult to stay on track

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

The conserved AAA-ATPase Msp1 confers organelle specificity to tail-anchored proteins

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

Incorporation of protein flexibility and conformational energy penalties in docking screens to improve ligand discovery

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex

[DOI] [PMC free article] [PubMed] [Google Scholar] 997.Pacher P, Szabo C

c ebp-lip drug C/EBP sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products

Frontiers

US$ 23.58

Min. order: 1 piece

4.5 (16 reviews)

Sold : Login>>